Hybrigenics
Hybrigenics offers a bioinformatics platforms to identify;validate;and inhibit protein interactions to develop therapeutics for cancer.
Hybrigenics has raised €13M across 2 funding rounds, most recently a round in Aug 2017. Based in Paris, France; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€13M
€13,388,000
Funding rounds
2
Investors
0
distinct backers
Active since
2009-09
latest 2017-08
Funding by year
EUR raised per yearHybrigenics — funding by year — interactive chart.
Data table
| Hybrigenics — funding by year | |
|---|---|
| 2009 | €6.6M |
| 2017 | €6.8M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood5
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-08-01 | Other | €6.8M | — | View deal → |
| 2009-09-01 | Other | €6.6M | — | View deal → |
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData